Read transcripts of debates in both Houses
Produced by Commons Library, Lords Library and Parliamentary Office Science and Technology
Search for Members by name, postcode, constituency and party
Learn about their experience, knowledge and interests
Celebrating people who have made Parliament a positive, inclusive working environment
Four staff networks for people to discuss and consider issues.
2018 marks 100 years since some women, and all men, could vote. Find out how you can join in
Sign up for the Your Parliament newsletter to find out how you can get involved
Take a tour of Parliament and enjoy a delicious afternoon tea by the River Thames
See some of the sights you’ll encounter on a tour of Parliament
Book a school visit, classroom workshop or teacher-training session
Access videos, worksheets, lesson plans and games
Follow this EDM by:
That this House welcomes the campaign by the Karen Clifford Skin Cancer Charity and Factor50 to improve access to treatments for patients with advanced melanoma; notes that in 2008 there were 11,767 new cases of malignant melanoma diagnosed in the UK and that whilst the majority of skin cancers are treatable, malignant melanoma is a particularly aggressive form of skin cancer causing the deaths of over 2,000 people in the UK each year; further notes that melanoma is the second most common cancer among young adults aged between 15 and 34 and that recent data published in the British Journal of Cancer predicts that the incidence rate of melanoma will increase more than any other cancer by 2030, rising by 52 per cent. for both men and women; is therefore deeply concerned that the National Institute for Health and Clinical Excellence(NICE) has issued draft guidance which restricts the use of Ipilimumab (Yervoy) for previously treated advanced malignant melanoma for patients in England and Wales; is furtherconcerned that there have been no licensed treatments for this patient group for over 30 years; and calls on NICE to reconsider its draft guidance for the benefit of patients with advanced melanoma, many of whom have young families.
Total number of signatures: 33
Showing 33 out of 33